Genfit

This study tested a drug called VS-01 in 15 adults with acute-on-chronic liver failure (sudden worsening of long-term liver disease) and fluid in the belly. The goal was to see if VS-01, given into the abdomen, improves liver function and survival when added to standard care. The…

This study tested a new medicine called VS-01 for people with severe confusion (hepatic encephalopathy) caused by liver cirrhosis. The goal was to see if adding VS-01 to standard care could help patients recover faster. Only 3 people took part before the study was stopped early, …